Replies to post #136952 on Biotech Values

[biomaven0]

Court-imposed royalties seem to be the trend:

http://www.fr.com/patentroyalties/

Given there is no way to unscramble the egg in terms of the Novartis/MNTA agreement, that would be handled by damages, and going forward I assume there would be a typical royalty determination.

Peter